Inovio Pharma (INO) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.24 --0%
EPS Growth %: +75.9%
Financial Fact:
General and administrative: 5.76M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +75.9%
Financial Fact:
General and administrative: 5.76M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($0.22), $0.05 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $125 thousand versus the consensus estimate of $339.28 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Cematrix wins $8.8M in new contracts, bringing YTD total to $43.2M
- LEEF Brands appoints Hirsh Jain to board as independent director
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
